Abstract
Objectives
Small-for-gestational-age (SGA) pregnancy is a condition often leading to labor induction due to concerns about the possibility of an increased risk for fetal morbidity and mortality. In this retrospective cohort study, we try to evaluate the safety of oral misoprostol for labor induction in near-term and term pregnancies in SGA fetuses compared to dinoprostone as well as to planned primary cesarean section.
Materials and methods
Retrospective analysis of labor indution and primary cesarean section in SGA pregnancies 37 weeks and beyond in a tertiary care centre. In total, 284 consecutive patients with SGA fetuses were included. 80 recieved oral misoprostol, 85 dinoprostone as vaginal Gel and 119 were delivered by means of primary cesarean section. Primary endpoints were umbilical aterial pH and APGAR 5′. Secondary endpoints were APGAR 1′ and 10′, rates of relevant acidosis with a pH < 7.11 and depressed children, NICU admissions and vaginal operative deliveries as well as cesarean sections after labor induction.
Results
No significant differences were found concerning the umbilical arterial pH. No significant differences were found concerning APGAR 5′ after labor induction; however, APGAR 5′ was significantly lower after primary cesarean section. Similar results were found concerning APGAR 1′, 10-min APGAR values were not significantly different. Rates of relevant acidosis and depressed children did not differ; no significant differences were found concerning NICU admissions between all groups and vaginal operative deliveries and CS rates after labor induciton.
Conclusion
Oral misoprosol is a safe method for labor induction in SGA near-term and term pregnancies and, concerning the neonatal outcome, comparable with other methods of labor induction or primary CS. Our study showed no adverse neonatal outcomes related to the use of oral misoprostol.
Similar content being viewed by others
References
Ewing AC, Ellington SR, Shapiro-Mendoza CK, Barfield WD, Kourtis AP (2017) Full-term small-for-gestational-age newborns in the US characteristics trends and morbidity. Matern Child Health J 21(4):786–796
Boers KE, van der Post JAM, Mol BWJ, van Lith JMM, Scherjon SA (2011) Labour and neonatal outcome in small for gestational age babies delivered beyond 360 weeks a retrospective cohort study. J Pregnancy. https://doi.org/10.1155/2011/293516
Veglia M, Cavallaro A, Papageorghiou A, Black R, Impey L (2018) Small-for-gestational-age babies after 37 weeks: impact study of risk-stratification protocol. Ultrasound Obstet Gynecol 52:66–71
Kazemier BM, Voskamp BJ, Ravelli AC, Pajkrt E, Groot CJ, Mol BW (2015) Optimal timing of delivery in small for gestational age fetuses near term: a national cohort study. Am J Perinatol 30:177–186
Pilliod RA, Cheng YW, Snowden JM, Doss AE, Caughey AB (2012) The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol 207:e311–e316
Intrauterine growth restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k, AWMF-Registry-No.: 015/080, October 2016). https://www.awmf.org/leitlinien/detail/II/015/080.html.
Ohel G, Ruach M (1996) Perinatal outcome of idiopathic small for gestational age pregnancies at term: the effect of antenatal diagnosis. Int J Obstet Gynecol 55:29–32
Penfield CA, Wing DA (2017) Labor induction techniques: which is the best? Obstet Gynecol Clin North Am 44:567–582
Keirse MJNC (1993) Prostaglandins in preinduction cervical ripening: meta-analysis of worldwide clinical experience. J Reprod Med 38:89–98
Thomas J, Fairclough A, Kavanagh J, Kelly AJ (2014) Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2:CD003101
Stephenson ML, Wing DA (2015) Misoprostol for induction of labor. Semin Perinatol 39:459–462
Alfirevic Z, Aflaifel N, Weeks A (2014) Oral misoprostol for induction of labour. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858
Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, Jones LV, Gyte G, Caldwell DM (2016) Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess 20:1–584
Ofir K, Lerner-Geva L, Boyko V, Zilberberg E, Schiff E, Simchen MJ (2013) Induction of labor for term small-for-gestational-age fetuses: what are the consequences? Eur J Obstet Gynecol Reprod Biol 171:257–261
Rossi RM, Warshak CR, Masters HR, Regan JK, Kritzer SA, Magner KP (2018) Comparison of prostaglandin and mechanical cervical ripening in the setting of small for gestational age neonates. J Matern Neonat Med 27:1–6
European Medicines Agency, Human Medicines Evaluation Division. List of nationally authorized medicinal products. Active substance: Dinoprostone. 2017; EMA/376407/2017
Hadlock FP, Harrist RB, Martinez-Poyer J (1991) In utero analysis of fetal growth: a sonographic weight standard. Radiology 181(1):129–133
Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 13:59
Gawlik S, Müller M, Kuon RJ, Szabo AZ, Keller D, Sohn C (2015) Timing of elective repeat cesarean does matter: Importance of avoiding early-term delivery especially ion diabetic patients. J Obstet Gynaecol 35:455–460
Carrapato MRG, Ferreira AM, Wataganara T (2017) Cesarean section: the pediatricians` views. J Matern Fetal Neonatal Med 30:2081–2085
Kotecha SJ, Gallacher DJ, Kotecha S (2016) The respiratory consequences of early-term birth and delivery by cesarean sections. Pediatr Respir Rev 19:49–55
Foeller ME, Cruz MO, Kominiarek MA, Hibbard JU (2015) Does induction with misoprostol impact the small for gestational age Neonate? Am J Perinatol 32:1311–1317
Tang OS, Gemzell-Danielsson K, Ho PC (2007) Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynecol Obstet 99:S160–S167
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
Joscha Steetskamp: data collection, statistics, and text editing/writing process. Elisabeth Bachmann: literature, data collection, and text editing. Parts of the results are used in Elisabeth Bachmann’s doctoral thesis. Annette Hasenburg: text editing, language correction, and literature. Marco Johannes Battista: language correction, writing process, and literature.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflicts of interest.
Ethical approval
Study design, data collection and data processing were in accordance with institutional ethical and data protection standards for retrospective studies of the University Medical Centre Mainz as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
All patients signed an agreement concerning anonymized data collection and processing for study purposes. In case of a missing agreement, the patient was not included.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Steetskamp, J., Bachmann, E., Hasenburg, A. et al. Safety of misoprostol for near-term and term induction in small-for-gestational-age pregnancies compared to dinoprostone and primary cesarean section: results of a retrospective cohort study. Arch Gynecol Obstet 302, 1369–1374 (2020). https://doi.org/10.1007/s00404-020-05703-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05703-2